Literature DB >> 1704683

Mechanism of action of H2-antagonists on histamine- or dimaprit-stimulated H2-receptors of spontaneously beating guinea-pig atrium.

M J Krielaart1, D M Veenstra, K J van Buuren.   

Abstract

Cimetidine, ranitidine and famotidine are antagonists of the histamine H2-receptors on the spontaneously beating right atrium of the guinea pig. When analyzed by the classical Schild method their pA2-values are respectively: 6.3, 6.8 and 7.7 with dimaprit as agonist and 5.8, 6.5 and 7.7 with histamine as agonist. Radioligand-displacement studies with [3H]-tiotidine as radioligand resulted in pKd values for cimetidine, ranitidine and famotidine of 6.3; 6.9 and 8.2 respectively. In dimaprit-stimulated atria all antagonists added at concentrations above their Kd values depressed the maximal increase in frequency. In the presence of histamine this effect was much less pronounced and only visible at concentrations of ranitidine and famotidine around 10.Kd. The rightward shift of the curves as well as the decrease in Emax are reversible but the dissociation constants of the antagonists are small (less than 10(-3) s-1). The spontaneously beating right atrium showed receptor reserve for histamine and virtually no receptor reserve for dimaprit. The results have been interpreted in a model in which H2-antagonists act mainly by competing with the agonist for the histamine receptor site but have in addition a distinct affinity for a secondary site on the receptor. Occupation of this site by the antagonist prevents building up of the stimulus elicited by the agonist and thus decreases the Emax. In systems with receptor reserve (histamine) the effect of antagonist binding to the secondary binding site is seen only at high concentration of antagonist while in absence of receptor reserve (dimaprit) the depression of Emax is directly visible. Simulations of the model show that the affinity of this secondary binding site is 50-(famotidine) to 100-(cimetidine and ranitidine) fold lower than for the agonist binding site.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1704683     DOI: 10.1007/bf02003217

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  27 in total

1.  Analysis of competitive antagonism when this property occurs as part of a pharmacological resultant.

Authors:  J W Black; V P Gerskowitch; P Leff; N P Shankley
Journal:  Br J Pharmacol       Date:  1986-11       Impact factor: 8.739

2.  Definition and antagonism of histamine H 2 -receptors.

Authors:  J W Black; W A Duncan; C J Durant; C R Ganellin; E M Parsons
Journal:  Nature       Date:  1972-04-21       Impact factor: 49.962

3.  Selectivity of partial agonists related to oxotremorine based on differences in muscarinic receptor reserve between the guinea pig ileum and urinary bladder.

Authors:  B Ringdahl
Journal:  Mol Pharmacol       Date:  1987-04       Impact factor: 4.436

4.  Effects of H2-receptor antagonists cimetidine, ranitidine, and ICI 125,211 on histamine-stimulated adenylate cyclase activity in guinea pig gastric mucosa.

Authors:  A M Cheret; F Pignal; M J Lewin
Journal:  Mol Pharmacol       Date:  1981-09       Impact factor: 4.436

5.  Ranitidine (AH 19065): a new potent, selective histamine H2-receptor antagonist [proceedings].

Authors:  J Bradshaw; R T Brittain; J W Clitherow; M J Daly; D Jack; B J Price; R Stables
Journal:  Br J Pharmacol       Date:  1979-07       Impact factor: 8.739

6.  Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves.

Authors:  A DeLean; P J Munson; D Rodbard
Journal:  Am J Physiol       Date:  1978-08

7.  The use of an in vitro binding assay to predict histamine H2-antagonist activity.

Authors:  D B Norris; G A Gajtkowski; T P Wood; T J Rising
Journal:  Agents Actions       Date:  1985-04

8.  Pharmacological basis for the induction of gastric carcinoid tumours in the rat by loxtidine, an insurmountable histamine H2-receptor blocking drug.

Authors:  R T Brittain; D Jack; J J Reeves; R Stables
Journal:  Br J Pharmacol       Date:  1985-08       Impact factor: 8.739

9.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03

10.  Inhibitory effect of famotidine on cat gastric secretion.

Authors:  G Coruzzi; G Bertaccini; M T Noci; G Dobrilla
Journal:  Agents Actions       Date:  1986-11
View more
  1 in total

Review 1.  The Roles of Cardiovascular H2-Histamine Receptors Under Normal and Pathophysiological Conditions.

Authors:  Joachim Neumann; Uwe Kirchhefer; Stefan Dhein; Britt Hofmann; Ulrich Gergs
Journal:  Front Pharmacol       Date:  2021-12-20       Impact factor: 5.810

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.